Mouwasat Medical Services Company (TADAWUL:4002)
Saudi Arabia · Delayed Price · Currency is SAR 61.20
-2.70 (-4.23%)
Aug 13, 2026, 3:19 PM AST
TADAWUL:4002 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,372 | 3,223 | 2,879 | 2,706 | 2,334 | 2,144 | |
Revenue Growth | 11.40% | 11.92% | 6.43% | 15.91% | 8.86% | 4.85% |
Cost of Revenue | 2,005 | 1,880 | 1,665 | 1,411 | 1,249 | 1,163 |
Gross Profit | 1,367 | 1,342 | 1,214 | 1,295 | 1,085 | 981.46 |
Selling, General & Admin | 502.38 | 482.62 | 419.76 | 429.25 | 400.78 | 359.53 |
Other Operating Expenses | -30.76 | -9.29 | -7.51 | -8.38 | -6.73 | - |
Operating Expenses | 468.39 | 463.49 | 490.65 | 538.12 | 412.32 | 359.53 |
Operating Income | 898.47 | 878.76 | 723.57 | 756.56 | 672.46 | 621.93 |
Interest Expense | -19.06 | -19.55 | -30.46 | -46.46 | -22.88 | -8.2 |
Interest & Investment Income | 15.5 | 22.44 | 22.19 | 6.48 | 0.58 | 0.32 |
Earnings From Equity Investments | - | - | - | 10.21 | 9.88 | 10.45 |
Other Non Operating Income (Expenses) | - | - | - | - | - | 7.71 |
EBT Excluding Unusual Items | 894.91 | 881.64 | 715.3 | 726.79 | 660.03 | 632.21 |
Gain (Loss) on Sale of Investments | - | - | -10.69 | - | - | - |
Gain (Loss) on Sale of Assets | 1.53 | 1.53 | 1.18 | 0.29 | 0.24 | -0.02 |
Pretax Income | 896.44 | 883.17 | 705.8 | 727.09 | 660.27 | 632.2 |
Income Tax Expense | 15.94 | 31.13 | 36.19 | 38.7 | 27.58 | 21.73 |
Earnings From Continuing Operations | 880.5 | 852.04 | 669.61 | 688.39 | 632.69 | 610.46 |
Minority Interest in Earnings | -30.09 | -30 | -23.85 | -30.7 | -33.38 | -32.3 |
Net Income | 850.41 | 822.04 | 645.76 | 657.69 | 599.31 | 578.16 |
Net Income to Common | 850.41 | 822.04 | 645.76 | 657.69 | 599.31 | 578.16 |
Net Income Growth | 20.54% | 27.30% | -1.81% | 9.74% | 3.66% | 9.47% |
Shares Outstanding (Basic) | 200 | 200 | 200 | 200 | 200 | 200 |
Shares Outstanding (Diluted) | 200 | 200 | 200 | 200 | 200 | 200 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | 4.25 | 4.11 | 3.23 | 3.29 | 3.00 | 2.89 |
EPS (Diluted) | 4.25 | 4.11 | 3.23 | 3.29 | 3.00 | 2.89 |
EPS Growth | 20.54% | 27.30% | -1.81% | 9.74% | 3.66% | 9.47% |
Free Cash Flow | 654.59 | 768.09 | 827.41 | 536.75 | 414.52 | 355.9 |
Free Cash Flow Per Share | 3.27 | 3.84 | 4.14 | 2.68 | 2.07 | 1.78 |
Dividend Per Share | 1.125 | 2.125 | 2.000 | 1.750 | 1.500 | 1.375 |
Dividend Growth | -62.50% | 6.25% | 14.29% | 16.67% | 9.09% | 10.00% |
Gross Margin | 40.53% | 41.65% | 42.17% | 47.85% | 46.48% | 45.77% |
Operating Margin | 26.64% | 27.27% | 25.13% | 27.96% | 28.81% | 29.01% |
Profit Margin | 25.22% | 25.51% | 22.43% | 24.31% | 25.68% | 26.96% |
Free Cash Flow Margin | 19.41% | 23.83% | 28.74% | 19.84% | 17.76% | 16.60% |
EBITDA | 1,148 | 1,116 | 955.56 | 974.55 | 855.25 | 773.9 |
EBITDA Margin | 34.05% | 34.64% | 33.19% | 36.02% | 36.64% | 36.09% |
D&A For EBITDA | 249.73 | 237.49 | 231.99 | 217.99 | 182.79 | 151.97 |
EBIT | 898.47 | 878.76 | 723.57 | 756.56 | 672.46 | 621.93 |
EBIT Margin | 26.64% | 27.27% | 25.13% | 27.96% | 28.81% | 29.01% |
Effective Tax Rate | 1.78% | 3.52% | 5.13% | 5.32% | 4.18% | 3.44% |
Revenue as Reported | 3,372 | 3,223 | 2,879 | 2,706 | 2,334 | 2,144 |
Advertising Expenses | - | 35.92 | 31.57 | 35.17 | 28.26 | 26.82 |